Exposing kinetic disparities between inflammasome readouts using time-resolved analysis
- PMID: 38867997
- PMCID: PMC11168392
- DOI: 10.1016/j.heliyon.2024.e32023
Exposing kinetic disparities between inflammasome readouts using time-resolved analysis
Abstract
The NLRP3 inflammasome is an intracellular multiprotein complex described to be involved in both an effective host response to infectious agents and various diseases. Investigation into the NLRP3 inflammasome has been extensive in the past two decades, and often revolves around the analysis of a few specific readouts, including ASC-speck formation, caspase-1 cleavage or activation, and cleavage and release of IL-1β and/or IL-18. Quantification of these readouts is commonly undertaken as an endpoint analysis, where the presence of each positive outcome is assessed independently of the others. In this study, we apply time-resolved analysis of a human macrophage model (differentiated THP-1-ASC-GFP cells) to commonly accessible methods. This approach yields the additional quantifiable metrics time-resolved absolute change and acceleration, allowing comparisons between readouts. Using this methodological approach, we reveal (potential) discrepancies between inflammasome-related readouts that otherwise might go undiscovered. The study highlights the importance of time-resolved data in general and may be further extended as well as incorporated into other areas of research.
Keywords: ASC-Specks; Cell response; Cytokines; Human macrophages; LDH leakage; Live-cell imaging; NLRP3 inflammasome; THP-1 cells.
© 2024 The Author(s).
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:co-author affiliated to Nanoxis Consulting AB - R.K. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures









Similar articles
-
Resting time after phorbol 12-myristate 13-acetate in THP-1 derived macrophages provides a non-biased model for the study of NLRP3 inflammasome.Front Immunol. 2022 Dec 22;13:958098. doi: 10.3389/fimmu.2022.958098. eCollection 2022. Front Immunol. 2022. PMID: 36618426 Free PMC article.
-
Naloxone inhibits nod-like receptor protein 3 inflammasome.J Surg Res. 2017 Nov;219:72-77. doi: 10.1016/j.jss.2017.05.119. Epub 2017 Jun 23. J Surg Res. 2017. PMID: 29078913
-
ASC Speck Formation after Inflammasome Activation in Primary Human Keratinocytes.Oxid Med Cell Longev. 2021 Nov 5;2021:7914829. doi: 10.1155/2021/7914829. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34777694 Free PMC article.
-
What are NLRP3-ASC specks? an experimental progress of 22 years of inflammasome research.Front Immunol. 2023 Jul 26;14:1188864. doi: 10.3389/fimmu.2023.1188864. eCollection 2023. Front Immunol. 2023. PMID: 37564644 Free PMC article. Review.
-
ALK-JNK signaling promotes NLRP3 inflammasome activation and pyroptosis via NEK7 during Streptococcus pneumoniae infection.Mol Immunol. 2023 May;157:78-90. doi: 10.1016/j.molimm.2023.03.016. Epub 2023 Mar 29. Mol Immunol. 2023. PMID: 37001294 Review.
Cited by
-
Exploring NLRP3-related phenotypic fingerprints in human macrophages using Cell Painting assay.iScience. 2025 Feb 5;28(3):111961. doi: 10.1016/j.isci.2025.111961. eCollection 2025 Mar 21. iScience. 2025. PMID: 40040812 Free PMC article.
References
-
- Soriano-Teruel P.M., García-Laínez G., Marco-Salvador M., Pardo J., Arias M., DeFord C., Merfort I., Vicent M.J., Pelegrín P., Sancho M., Orzáez M. Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases. Cell Death & Disease. 2021;12:1155. doi: 10.1038/s41419-021-04420-1. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous